Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments. The vaccine, which is still at the earliest research stage, has been tested on mice. The method can potentially also be used to develop different forms of vaccines, for example vaccines for autoimmune disorders.
Allergy has become a common disease, and hundreds of millions around the world suffer from allergic rhinitis, or hay fever, with discomforts like colds, fatigue and red, itchy eyes. Now researchers from the Faculty of Health and Medical Sciences have come one step closer to putting an end to this development. The researchers have developed a vaccine that prevents the development of allergy in mice. It is based on specific sugar molecules that may increase the effect of treatments and reduce treatment times.
‘We believe the current form of vaccination can be optimised. Initially, our goal was to create an artificial production of the proteins on which allergy vaccines are based and to optimise the proteins making them more effective and fast-working. We did that using sugar molecules. In the long term our goal is to reduce
Article originally posted at